• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Percodan (oxycodone and aspirin) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – March 2010

 

Summary View

 

PRECAUTIONS 

Information for Patient/Caregivers
  • Patients should be advised that Percodan tablets may cause or worsen constipation, as generally occurs with all opioids. They should discuss any past history of constipation with their prescribing physician so a management plan may be initiated.